Federal
Register Notices > Notices of
Registration - 2006
>
American Radiolabeled Chemicals, Inc.
FR Doc E6-21879 [Federal Register: December 22, 2006 (Volume 71, Number 246)]
[Notices] [Page 77062-77063] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22de06-102]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances Notice of Registration
By Notice dated August 15, 2006, and published in the Federal Register on
August 22, 2006, (71 FR 48944-48945), American Radiolabeled Chemicals, Inc., 101
Arc Drive, St. Louis, Missouri 63146, made application by renewal and by
correspondence dated June 2, 2006, to the Drug Enforcement Administration (DEA)
to be registered as a bulk manufacturer of the basic classes of controlled
substances listed in schedule I and II:
Drug
|
Schedule
|
Gamma hydroxybutyric acid (2010)
|
I
|
Ibogaine (7260)
|
I
|
Lysergic acid diethylamide (7315)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Dimethyltryptamine (7435)
|
I
|
Dihydromorphine (9145)
|
I
|
Amphetamine (1100)
|
II
|
Methamphetamine (1105)
|
II
|
Amobarbital (2125)
|
II
|
Phencyclidine (7471)
|
II
|
Phenylacetone (8501)
|
II
|
Cocaine (9041)
|
II
|
Codeine (9050)
|
II
|
Dihydrocodeine (9120)
|
II
|
Oxycodone (9143)
|
II
|
Hydromorphone (9150)
|
II
|
Ecgonine (9180)
|
II
|
Hydrocodone (9193)
|
II
|
Meperidine (9230)
|
II
|
Metazocine (9240)
|
II
|
Morphine (9300)
|
II
|
Thebaine (9333)
|
II
|
Oxymorphone (9652)
|
II
|
Fentanyl (9801)
|
II
|
The company plans to manufacture small quantities of the listed controlled
substances as radiolabeled compounds for biochemical research.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of American
Radiolabeled Chemicals, Inc. to manufacture the listed basic classes of
controlled substances is consistent
[[Page 77063]]
with the public interest at this time. DEA has investigated American
Radiolabeled Chemicals, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included inspection
and testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance
with 21 CFR
1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration.
[FR Doc. E6-21879 Filed 12-21-06; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|